ASPERGILLOSIS
Clinical trials for ASPERGILLOSIS explained in plain language.
Never miss a new study
Get alerted when new ASPERGILLOSIS trials appear
Sign up with your email to follow new studies for ASPERGILLOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Korean study monitors fungal drug safety
Disease control CompletedThis study looked at how safe and effective the drug Cresemba is for adults with serious fungal infections like invasive aspergillosis or mucormycosis. It involved 94 people in Korea who were already prescribed the drug. The main goal was to track any side effects and see if the …
Matched conditions: ASPERGILLOSIS
Sponsor: Pfizer • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Study aims to perfect antifungal dosing for sickest ICU patients
Knowledge-focused CompletedThis study looked at 32 adults in the ICU on ECMO (a heart-lung machine) who had severe influenza or COVID-19 and a serious fungal lung infection called aspergillosis. Researchers measured how the antifungal drug voriconazole moved through their bodies to find the best dose. The …
Matched conditions: ASPERGILLOSIS
Sponsor: University Hospitals, Leicester • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Hidden fungal threat in COVID-19 ICU patients revealed
Knowledge-focused CompletedThis study tracked 219 adults with severe COVID-19 who needed a ventilator to breathe. Researchers wanted to see how many also developed serious fungal infections, especially a lung infection called aspergillosis. They used standard tests to check for fungi, but did not give any …
Matched conditions: ASPERGILLOSIS
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC